Trial profile

Induction of Labor With Oxytocin: When Should Oxytocin Be Held?

ClinicalTrials.gov: NCT00957593

Design and population

Sponsor

Lehigh Valley Hospital

Phase

Phase 4

Design

Randomized controlled trial

Overall status

Completed

Enrollment

Planned enrollment

—

Actual enrollment

—

Population summary

Pregnant women undergoing labor induction with oxytocin.

Sex eligibility

—

Reproductive and life-stage eligibility

Pregnancy eligibility

—

Lactation eligibility

—

Reproductive-potential requirements

—

Sex-stratification / analysis plan

—

Medicines studied

Oxytocin

Posterior pituitary hormone / peptide

What can and cannot be concluded for women

Conclusions depend on whether women were enrolled in sufficient numbers, whether a sex analysis was prespecified and powered, and what life-stage data were reported. Use the enrollment and analysis details above to judge how far the results can be generalized, and verify the current trial status at ClinicalTrials.gov.

Sources

Primary records

ClinicalTrials.gov
clinical trial registry
Public registry for verifying trial design, enrollment, status, and results.

Direct registry link: verify status and results at ClinicalTrials.gov.

Medical disclaimer: Her Health Peptides publishes educational, source-linked summaries. We do not provide individualized medical advice, diagnosis, or treatment recommendations. Always talk with a licensed clinician about your specific situation, especially if you are pregnant, breastfeeding, planning pregnancy, or taking other medicines.